Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Jenna who wrote (46357)	6/25/1999 6:21:00 AM
From: puborectalis	Read Replies (1) \| Respond to of 120523

Take a another look at Netperceptions..Large Agreements to be finalized soon! channelseven.com >>NetPerceptions announced that the technology will be integrated into NetGravity's AdServer immediately. NetGravity clients such as Business Week Online and Hollywood Online will have access to the data generated by NetPerceptions. Larsen said he expects agreements with other ad servers and ad networks to be finalized within a month. NetPerceptions is best known in the industry for its personalization and recommendation software, currently used by more than 80 ecommerce sites including Amazon.com. The ad targeting business is a new one for the company. Larsen expects his client roster to grow to 50 by the end of the year.<< .......................................................... looks good in my opinion. we should see NETP valued much higher in the near future. i won't miss out on that one. i used today's weakness to accumulate. will be buying more tommorrow in germany. Hetty

To: Jenna who wrote (46357)	6/25/1999 8:50:00 AM
From: kendall harmon	Respond to of 120523

OXE-from business week OEC Could Get Back on the Beam Watch out for new sizzle at OEC Medical Systems (OXE), a leader in computer-based instruments, primarily X-ray and fluoroscopic imaging systems. Some big stakeholders aren't too happy. The stock has been on the ropes: down 27% this year, to 22. Not even OEC's announcement in May--that it has developed a ''breakthrough product'' in imaging systems--bolstered the price. What to do? Some big shareholders are said to be in talks with an investor group interested in taking an active role in OEC. A year ago, one big stakeholder was approached by a medical-device company offering to buy his holdings. This investor declined the offer; the stock was then at 30. He believes OEC is worth 40. This time, he may be tempted to do a deal with another group. William Harnisch of Forstmann-Leff International, which has a 25% stake in OEC, declined to comment on whether he has had an offer for his holdings. Rumors are that a large medical-device company has been in touch with Harnisch. Fidelity holds about 7% of the stock. Neither OEC Chairman Ruediger Naumann-Etienne nor CEO Joseph Pepper would comment on whether the company had been approached. ''We're working closely [with one of our big holders]'' for another institution to buy his stake in the company, says Pepper. Adds Naumann-Etienne: ''We'll keep developing new technologies and products, and continue to buy back our own shares.'' Analyst Vincent Colicchio of Southwest Securities, who rates OEC a buy, has increased his price target for the stock from 28 to 31, based on his fiscal 1999 operating earnings forecast of $1.43 a share. He expects $1.70 in 2000.